Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-ups

Hospital stocks in India fell sharply after the Supreme Court questioned steep mark-ups on medicines sold through corporate hospitals. Apollo, Fortis, and KIMS were among the worst-hit, with their shares plummeting up to 6%. This decline is a concern for the healthcare sector, as it may indicate a loss of investor confidence in the industry. The Supreme Court's intervention could lead to increased scrutiny of hospital pricing and potentially affect the profitability of these companies.

Why it matters

The Supreme Court's concerns over drug mark-ups are putting pressure on hospital stocks. This could lead to increased regulatory scrutiny and potential losses for these companies.

Market impact

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to Economic Times. For information only — not financial advice.